350 related articles for article (PubMed ID: 26260914)
1. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
2. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
3. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
[TBL] [Abstract][Full Text] [Related]
5. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
[TBL] [Abstract][Full Text] [Related]
6. Methylated TMS1 and DAPK genes predict prognosis and response to chemotherapy in gastric cancer.
Kato K; Iida S; Uetake H; Takagi Y; Yamashita T; Inokuchi M; Yamada H; Kojima K; Sugihara K
Int J Cancer; 2008 Feb; 122(3):603-8. PubMed ID: 17943730
[TBL] [Abstract][Full Text] [Related]
7. The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance.
Liu XF; Zhu SG; Zhang H; Xu Z; Su HL; Li SJ; Zhou XT
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):449-53. PubMed ID: 16911948
[TBL] [Abstract][Full Text] [Related]
8. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
[TBL] [Abstract][Full Text] [Related]
9. Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang R; Yu J; Fan D; Hao X
Oncotarget; 2015 Feb; 6(6):4482-95. PubMed ID: 25714013
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer.
Hou YC; Deng JY; Zhang RP; Xie XM; Cui JL; Wu WP; Hao XS; Liang H
Cancer Biomark; 2015; 15(5):567-73. PubMed ID: 26406945
[TBL] [Abstract][Full Text] [Related]
11. Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer.
Deng J; Liang H; Zhang R; Dong Q; Hou Y; Yu J; Fan D; Hao X
Oncotarget; 2014 Sep; 5(17):7420-30. PubMed ID: 25277182
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
[TBL] [Abstract][Full Text] [Related]
13. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer.
Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D
Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of TMS1/ASC in ovarian cancer.
Terasawa K; Sagae S; Toyota M; Tsukada K; Ogi K; Satoh A; Mita H; Imai K; Tokino T; Kudo R
Clin Cancer Res; 2004 Mar; 10(6):2000-6. PubMed ID: 15041718
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma.
Stone AR; Bobo W; Brat DJ; Devi NS; Van Meir EG; Vertino PM
Am J Pathol; 2004 Oct; 165(4):1151-61. PubMed ID: 15466382
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
[TBL] [Abstract][Full Text] [Related]
18. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer.
Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ
Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of apoptosis-associated speck-like protein containing a CARD gene promoter methylation in resectable non-small-cell lung cancer.
Zhang Z; Tan S; Zhang L
Clin Lung Cancer; 2006 Jul; 8(1):62-5. PubMed ID: 16870048
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
Hu G; Qin L; Zhang X; Ye G; Huang T
Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]